4

OWNERSHIP DOCUMENT

Company: Petros Pharmaceuticals, Inc.
Filed: April 28, 2023
Period of Report: April 26, 2023
Accession Number: 0001104659-23-053224

View Document ↗ View on SEC.gov ↗